본문 바로가기
KERD
논문KCI 등재

Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment

2

조회

0

다운로드

12

인용

0

참고문헌

키워드

초록

Herpes zoster (HZ) is a transient disease caused by the reactivation of latent varicella zoster virus (VZV) in spinal or cranial sensory ganglia. It is characterized by a painful rash in the affected dermatome. Postherpetic neuralgia (PHN) is the most troublesome side effect associated with HZ. However, PHN is often resistant to current analgesic treatments such as antidepressants, anticonvulsants, opioids, and topical agents including lidocaine patches and capsaicin cream and can persist for several years. The risk factors for reactivation of HZ include advanced age and compromised cell-mediated immunity (CMI). Early diagnosis and treatment with antiviral agents plus intervention treatments is believed to shorten the duration and severity of acute HZ and reduce the risk of PHN. Prophylactic vaccination against VZV can be the best option to prevent or reduce the incidence of HZ and PHN. This review focuses on the pathophysiology, clinical features, and management of HZ and PHN, as well as the efficacy of the HZ vaccine. (Korean J Pain 2015; 28: 177-184)

Abstract

Herpes zoster (HZ) is a transient disease caused by the reactivation of latent varicella zoster virus (VZV) in spinal or cranial sensory ganglia. It is characterized by a painful rash in the affected dermatome. Postherpetic neuralgia (PHN) is the most troublesome side effect associated with HZ. However, PHN is often resistant to current analgesic treatments such as antidepressants, anticonvulsants, opioids, and topical agents including lidocaine patches and capsaicin cream and can persist for several years. The risk factors for reactivation of HZ include advanced age and compromised cell-mediated immunity (CMI). Early diagnosis and treatment with antiviral agents plus intervention treatments is believed to shorten the duration and severity of acute HZ and reduce the risk of PHN. Prophylactic vaccination against VZV can be the best option to prevent or reduce the incidence of HZ and PHN. This review focuses on the pathophysiology, clinical features, and management of HZ and PHN, as well as the efficacy of the HZ vaccine. (Korean J Pain 2015; 28: 177-184)

참고문헌 (55)

  1. Gauthier A, "Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom", Epidemiol Infect, 137, pp.38~47 (2009)
  2. Yawn BP, "A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction", Mayo Clin Proc, 82, pp.1341~1349 (2007)
  3. Arvin A., "Aging, immunity, and the varicella-zoster virus", N Engl J Med, 352, pp.2266~2267 (2005)
  4. Thyregod HG, "Natural history of pain following herpes zoster", Pain, 128, pp.148~156 (2007)
  5. Yawn BP, "The global epidemiology of herpes zoster", Neurology, 81, pp.928~930 (2013)
  6. Panlilio LM, "Current management of postherpetic neuralgia", Neurologist, 8, pp.339~350 (2002)
  7. Fields HL, "Postherpetic neuralgia:irritable nociceptors and deafferentation", Neurobiol Dis, 5, pp.209~227 (1998)
  8. Baron R, "Mechanisms of postherpetic neuralgia--we are hot on the scent", Pain, 140, pp.395~396 (2008)
  9. Chernev I, "Segmental zoster abdominal paresis(zoster pseudohernia) : a review of the literature", PM R, 5, pp.786~790 (2013)
  10. Oaklander AL, "The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles", Pain, 92, pp.139~145 (2001)
  11. Truini A, "Pathophysiology of pain in postherpetic neuralgia : a clinical and neurophysiological study", Pain, 140, pp.405~410 (2008)
  12. Watson CP, "The prognosis with postherpetic neuralgia", Pain, 46, pp.195~199 (1991)
  13. Garry EM, "Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs", Pain, 118, pp.97~111 (2005)
  14. Premkumar LS, "Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions", AAPS J, 12, pp.361~370 (2010)
  15. Baron R, "Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment", Lancet Neurol, 9, pp.807~819 (2010)
  16. Kidd BL, "Mechanisms of inflammatory pain", Br J Anaesth, 87, pp.3~11 (2001)
  17. Meller ST, "A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain", Neuroscience, 48, pp.501~524 (1992)
  18. Mannion RJ, "Neurotrophins : peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity", Proc Natl Acad Sci U S A, 96, pp.9385~9390 (1999)
  19. Dworkin RH, "Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia", J Pain, 9, pp.S37~S44 (2008)
  20. Francis Sahngun Nahm, "Survey on the Treatment of Postherpetic Neuralgia in Korea; Multicenter Study of 1,414 Patients", The Korean Journal of Pain, 26(1), pp.21~26 (2013), 대한통증학회
  21. Arani RB, "Phase specific analysis of herpes zoster associated pain data : a new statistical approach", Stat Med, 20, pp.2429~2439 (2001)
  22. Coen PG, "Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?", Eur J Pain, 10, pp.695~700 (2006)
  23. Jung BF, "Risk factors for postherpetic neuralgia in patients with herpes zoster", Neurology, 62, pp.1545~1551 (2004)
  24. Volpi A, "Clinical and psychosocial correlates of post-herpetic neuralgia", J Med Virol, 80, pp.1646~1652 (2008)
  25. Espy MJ, "Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR", J Clin Microbiol, 38, pp.3187~3189 (2000)
  26. Shafran SD, "Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial", J Clin Virol, 29, pp.248~253 (2004)
  27. Shen MC, "parallelgroup trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster", J Microbiol Immunol Infect, 37, pp.75~81 (2004)
  28. Sampathkumar P, "Herpes zoster(shingles)and postherpetic neuralgia", Mayo Clin Proc, 84, pp.274~280 (2009)
  29. De Clercq E, "Selective anti-herpesvirus agents", Antivir Chem Chemother, 23, pp.93~101 (2013)
  30. Whitley RJ, "The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group", Ann Intern Med, 125, pp.376~383 (1996)
  31. Dworkin RH, "A randomized, placebocontrolled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 2009; 142: 209-17.", Pain, 142, pp.209~217 (2009)
  32. van Wijck AJ, "The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia : a randomised controlled trial", Lancet, 367, pp.219~224 (2006)
  33. Pasqualucci A, "Prevention of post-herpetic neuralgia : acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone", Acta Anaesthesiol Scand, 44, pp.910~918 (2000)
  34. Kumar V, "Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia : an appraisal of current evidence", Reg Anesth Pain Med, 29, pp.454~461 (2004)
  35. Baidya DK, "Analgesic efficacy and safety of thoracic paravertebral and epidural analgesia for thoracic surgery : a systematic review and meta-analysis", Interact Cardiovasc Thorac Surg, 18, pp.626~635 (2014)
  36. Makharita MY, "Single paravertebral injection for acute thoracic herpes zoster : a randomized controlled trial", Pain Pract, 15, pp.229~235 (2015)
  37. Ji G, "The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster", Anesth Analg, 109, pp.1651~1655 (2009)
  38. Makharita MY, "Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia", Pain Physician, 15, pp.467~474 (2012)
  39. Hempenstall K, "Analgesic therapy in postherpetic neuralgia: a quantitative systematic review", PLoS Med, 2, pp.e164~ (2005)
  40. Vieweg WV, "Tricyclic antidepressants, QT interval prolongation, and torsade de pointes", Psychosomatics, 45, pp.371~377 (2004)
  41. Zin CS, "An update on the pharmacological management of postherpetic neuralgia and painful diabetic neuropathy", CNS Drugs, 22, pp.417~442 (2008)
  42. Rowbotham M, "Gabapentin for the treatment of postherpetic neuralgia : a randomized controlled trial", JAMA, 280, pp.1837~1842 (1998)
  43. Sabatowski R, "Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial", Pain, 109, pp.26~35 (2004)
  44. Christo PJ, "Post-herpetic neuralgia in older adults : evidence-based approaches to clinical management", Drugs Aging, 24, pp.1~19 (2007)
  45. Watson CP, "Controlled-release oxycodone relieves neuropathic pain : a randomized controlled trial in painful diabetic neuropathy", Pain, 105, pp.71~78 (2003)
  46. Raja SN, "Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial", Neurology, 59, pp.1015~1021 (2002)
  47. Boureau F, "Tramadol in postherpetic neuralgia: a randomized, double-blind, placebocontrolled trial", Pain, 104, pp.323~331 (2003)
  48. Rowbotham MC, "Lidocaine patch : double-blind controlled study of a new treatment method for post-herpetic neuralgia", Pain, 65, pp.39~44 (1996)
  49. Galer BS, "The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehiclecontrolled, 3-week efficacy study with use of the neuropathic pain scale", Clin J Pain, 18, pp.297~301 (2002)
  50. Watson CP, "A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia", Clin Ther, 15, pp.510~526 (1993)
  51. Kotani N, "Intrathecal methylprednisolone for intractable postherpetic neuralgia", N Engl J Med, 343, pp.1514~1519 (2000)
  52. Doi K, "Intercostal nerve block with 5% tetracaine for chronic pain syndromes", J Clin Anesth, 14, pp.39~41 (2002)
  53. Young Hoon Jeon, "Spinal Cord Stimulation in Pain Management: A Review", The Korean Journal of Pain, 25(3), pp.143~150 (2012), 대한통증학회[DOI]
  54. Harke H, "Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain", Anesth Analg, 94, pp.694~700 (2002)
  55. Oxman MN, "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults", N Engl J Med, 352, pp.2271~2284 (2005)

관련 논문AI추천

이 간행물의 다른 논문 (9건)